Brief: Nanoform Collaborates With Takeda On Their Plasma-Derived Therapy Development

Nanoform Finland Oyj

15/08/2024 06:21

Aug 15 (Reuters) - Nanoform Finland Oyj  NANOFH.HE :
    * NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED
THERAPY DEVELOPMENT
    * FIRST RESULTS OF THESE STUDIES ARE EXPECTED BY EARLY 2025
    * TO PROVIDE NON-GMP NANOMATERIAL TO TAKEDA FOR IN VIVO
STUDIES
    * VALUE OF PROJECT IN LINE WITH NANOFORM'S BUSINESS MODEL
    * PARTIES SIGN PRE-CLINICAL DEVELOPMENT AGREEMENT

Source text for Eikon:  ID:nWkrbvHWSH 
Further company coverage:  NANOFH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))